Cannabis Radio News
Cannabis Radio News

GW's Epidiolex Passes 3rd Phase 3 Trial

October 20, 20165 min
GW Pharma has cleared another hurdle in gaining FDA approval for its drug called Epidiolex, boosting stock value for the British drug maker.

Chat About GW's Epidiolex Passes 3rd Phase 3 Trial